You are here: Industry Insights > USFDA

News List

Granules India gets EIR from USFDA for OmniChem facility expressbpd
October 09, 2017
Granules India has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Visakhapatnam, Andhra Pradesh.
Strides Shasun receives USFDA approval for Potassium Citrate Extended-Release Tablets expressbpd
September 13, 2017
Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq
Lupin gets USFDA nod to market anti-infections tablets expressbpd
September 12, 2017
The company’s product is a generic version of Pfizer’s Vibra tablets
Zydus Cadila gets USFDA nod for injection to patients taking organ transplantation expressbpd
September 04, 2017
The approval is for Mycophenolate Mofetil injection of strength 500mg/vial
Pfizer bags USFDA approval for Besponsa biospectrumasia
August 22, 2017
The regulatory agency approved the Besponsa, drug fro the treatment of leukemia, under Priority Review and Breakthrough Therapy status
Zydus Cadila gets USFDA nod to market HIV drug expressbpd
August 10, 2017
The tablets will be produced at the groups formulations manufacturing facility at the Pharma SEZ in Ahmedabad
Promethazine by Strides Shasun approved by USFDA biospectrumasia
July 04, 2017
The product will be manufactured at the company’s flagship facility at Bangalore and marketed by Strides Pharma Inc. in the US Market
Tampered evidence and serialization pharmaasia
June 30, 2017
By Emma Chen, marketing manager, Essentra
USFDA approves the generic version of Lialda of an Indian drug firm Zydus Cadila biospectrumasia
June 15, 2017
The generic version of Lialda presents a significant opportunity for the Gujarat-based firm Zydus Cadila in the US.
USFDA approval for Alembic Pharma biospectrumasia
April 11, 2017
Fluoxetine is a generic version of Prozac tablets manufactured by Eli Lilly and Company

Previous page 1 2 3 4 5 Next page